A significant amount of imaging orders in emergency settings are inappropriate

Imaging exams ordered in emergency departments are often inappropriate and do not yield any significant findings, a new analysis suggests. 

The study, published in Emergency Radiology, examined all ultrasound, CT and MRI exams ordered in the emergency department of a large academic center over a three-month period and found that, in some cases, more than half of the requests were inappropriate. Of those misguided requests, nearly two-thirds unearthed zero suspicious findings. 

The team used the American College of Radiology Appropriateness Criteria to guide their determinations, and then compared the final report to the ordering providers’ initial clinical suspicions. 

Nearly 60% of orders included in the analysis were deemed inappropriate, with the highest rate being seen in ultrasound, nearly 60% of which were not compatible with their initial clinical suspicion. MRI orders were next  at 33%, followed by CT orders, at 29%. 

Compared to inappropriate orders, appropriate orders were three times more likely to result in findings compatible with providers’ initial clinical suspicions. 

A general lack of awareness pertaining to ACR appropriateness criteria could be a driving factor behind the misguided requisitions, the authors suggested. 

“Despite the wide availability and free access to the ACR Appropriateness Criteria, a lack of awareness likely contributes to their underutilization, resulting in not only overuse of imaging but also suboptimal modality choices, often leading to multiple orders during the same visit,” senior author Bruno Hochhegger, MD, PhD, of the University of Florida, and colleagues explained, adding that concerns about missing something underlying and the resultant malpractice consequences could also be to blame. 

Regardless, inappropriate orders are problematic for multiple reasons, the group continued. 

“Besides the low diagnostic yield, inappropriate orders also contribute to the increasing healthcare cost burden and expose patients to unnecessary ionizing radiation." 

Hannah murhphy headshot

In addition to her background in journalism, Hannah also has patient-facing experience in clinical settings, having spent more than 12 years working as a registered rad tech. She joined Innovate Healthcare in 2021 and has since put her unique expertise to use in her editorial role with Health Imaging.

Around the web

GE HealthCare's flurpiridaz, the PET radiotracer that recently received FDA approval, offers several key benefits over SPECT. Jamshid Maddahi, MD, discussed the details in an exclusive interview. 

Ultrafast MCE could go on to become a go-to treatment option for obstructive coronary artery disease, according to the authors of a new first-in-human clinical study.

Elucid's PlaqueIQ was trained to turn CCTA images into interactive 3D reports that help physicians visualize the presence of atherosclerosis.

Trimed Popup
Trimed Popup